Saturday, September 24, 2011

Roche expects $10 billion sales for HDL drug

"This is the order of magnitude we are looking at," Jean-Jacques Garaud said in an interview on Friday, when asked if dalcetrapib could produce annual sales in the $10 billion range.

Posted via email from Jack's posterous

No comments: